|
1
Diffuse Hormonal Systems
|
Hans Clevers and Talya L. Dayton |
|
2
Carcinoid Tumors
|
Aaron Vinik, MD, PhD, FCP, MACP, FACE, Marybeth S. Hughes, M.D., F.A.C.S., Eric Feliberti, MD, FACS, Roger R Perry, M.D., FACS, Carolina Casellini, M.D., Mark Sinesi, MD, PhD, Harlan Vingan MD and Lester Johnson, MD |
|
3
Multiple Endocrine Neoplasia Type 1
|
Aaron Vinik, MD, PhD, FCP, MACP, FACE, Roger R Perry, M.D., FACS, Marybeth S. Hughes, M.D., F.A.C.S. and Eric Feliberti, MD, FACS |
|
4
Multiple Endocrine Neoplasia Type 2A (including Familial Medullary Carcinoma) and Type 2B
|
Marybeth S. Hughes, M.D., F.A.C.S., Eric Feliberti, MD, FACS, Roger R Perry, M.D., FACS and Aaron Vinik, MD, PhD, FCP, MACP, FACE |
|
5
Pathophysiology and Treatment of Pancreatic Neuroendocrine Tumors (PNETs): New Developments
|
Aaron Vinik, MD, PhD, FCP, MACP, FACE, Roger R Perry, M.D., FACS, Carolina Casellini, M.D., Marybeth S. Hughes, M.D., F.A.C.S. and Eric Feliberti, MD, FACS |
|
6
Gastrinoma
|
Robert T. Jensen, MD |
|
7
Insulinoma
|
Wouter W. de Herder, MD, PhD, Wouter T. Zandee, MD, PhD and Johannes Hofland, MD, PhD |
|
8
Vasoactive Intestinal Peptide Tumor (VIPoma)
|
Wouter T. Zandee, MD, PhD, Johannes Hofland, MD, PhD and Wouter W. de Herder, MD, PhD |
|
9
Glucagonoma Syndrome
|
Wouter T. Zandee, MD, PhD, Johannes Hofland, MD, PhD and Wouter W. de Herder, MD, PhD |
|
10
Somatostatinoma
|
Wouter W. de Herder, MD, PhD, Wouter T. Zandee, MD, PhD and Johannes Hofland, MD, PhD |
|
11
CCKoma
|
Wouter W. de Herder, MD, PhD and Johannes Hofland, MD, PhD |
|
12
Ghrelinoma
|
Wouter T. Zandee, MD, PhD, Johannes Hofland, MD, PhD, Aart J. van de Lely, MD, PhD and Wouter W. de Herder, MD |
|
13
Paraneoplastic Syndromes Related to Neuroendocrine Tumors
|
Marina Tsoli, MD, PhD, Georgios K. Dimitriadis, Ioannis I. Androulakis, Gregory Kaltsas, MD, PHD, FRCP and Ashley Grossman, BA, BSc, MD, PhD (Hon. Causa), FRCP, FMedSci |
